Cellabs is a leading biotechnology company based in Sydney Australia which specialises in the design, development, and manufacture of immunodiagnostic kits for tropical and infectious diseases. Cellabs is the oldest private biotechnology company in Australia and continues to supply customers worldwide with superior quality products.

Cellabs has specifically targeted those diseases that afflict millions of people worldwide and was one of the first companies to provide diagnostics for Malaria, Cryptosporidiosis, Giardiasis, and Chlamydial diseases. Cellabs also has a long history of market leadership with a number of its products; most notably its antibody reagent for Cryptosporidium identification. The Crypto Cel Antibody Reagent is the preferred antibody of the UK Drinking Water Inspectorate.

Cellabs products are available in three convenient formats; direct (DFA) and indirect (IFA) immunofluorescent assays, enzyme-linked immunosorbent assay (ELISA), and rapid tests. All products are CE Marked according to ISO13485:2003. We are continuing to develop new products to complement our existing product range through Research and Development.

In 2005, Cellabs sponsored a number of indivuals and organisations in their latest ventures. Read more about it in our We Support section.

Thank you for visiting our website.